World Markets

Sinopharm COVID-19 vaccine phase 3 trial begins in Abu Dhabi

Credit: REUTERS/BOBBY YIP

Chinese state-owned pharmaceutical company Sinopharm has begun phase 3 clinical trials of a COVID-19 vaccine in the emirate of Abu Dhabi, the Abu Dhabi government media office said on Thursday.

DUBAI, July 16 (Reuters) - Chinese state-owned pharmaceutical company Sinopharm has begun phase 3 clinical trials of a COVID-19 vaccine in the emirate of Abu Dhabi, the Abu Dhabi government media office said on Thursday.

The human trial taking place in Abu Dhabi, part of the United Arab Emirates, is a partnership between Sinopharm's China National Biotec Group (CNBG), Abu Dhabi based artificial intelligence and cloud computing company Group 42 and the Abu Dhabi Department of Health.

(Reporting by Lisa Barrington; Editing by Alison Williams)

((lisa.barrington@thomsonreuters.com;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Latest Markets Videos

    Reuters

    Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

    Learn More